July 2021
Chronic Lymphocytic Leukemia (CLL)
The goal of the Patient-to-Patient Diverse Clinical Trial Profiles program is to bridge the gap between patients who have participated in clinical trials and patients who have not yet participated for various reasons.
- CLL Patient-to-Patient Diverse Clinical Trial Profiles – Learn from a diverse group of patients sharing their experience within a clinical trial and advice they might offer others.
- Clinical Trial Cornerstone Resource Directory – A patient centric one-stop aggregation of resources during a clinical trial.
CLL Patient-to-Patient Diverse Clinical Trial Profiles
Clinical Trial Cornerstone Resource Directory
This program is supported by Pharmacyclics, an AbbVie Company and Janssen and through generous donations from people like you.